SOAT1 and chronic kidney disease: In CKD patients, increased SREBP expression accelerates cholesterol synthesis, leading to increased sterol O-acyltransferase 1 (SOAT1) activity and reduced neutral cholesterol ester hydrolase (NCEH) activity.